Coronary Physiology Systems Market Report 2026

Coronary Physiology Systems Market Overview

• Coronary Physiology Systems market size has reached to $1.34 billion in 2025 • Expected to grow to $2.12 billion in 2030 at a compound annual growth rate (CAGR) of 9.7% • Growth Driver: Surge In Coronary Artery Disease Fueling The Growth Of The Market Due To Rising Sedentary Lifestyles And Cardiovascular Risk • Market Trend: Advancements In Image-Based Quantitative Flow Ratio (QFR) Technology Enhance Precision In Coronary Physiology Assessment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Coronary Physiology Systems Market?

Coronary physiology systems are advanced diagnostic tools used during cardiac catheterization to evaluate pressure and blood flow within the coronary arteries. They help determine whether a narrowing in the artery significantly limits blood supply to the heart muscle. The coronary physiology system enables cardiologists to choose the most appropriate treatment approach, such as intervention or medical therapy, while minimizing unnecessary procedures. The main product types of coronary physiology systems include pressure wire systems, flow measurement systems, integrated systems, and other product types. Pressure wire systems are specialized devices used to measure blood pressure and flow within coronary arteries to guide interventional procedures. The modalities include invasive and non-invasive. They find application in fractional flow reserve (FFR), instantaneous wave-free ratio (iFR), coronary flow reserve (CFR), and other applications, serving end users including hospitals, ambulatory surgical centers, specialty clinics, and other end-users.

What Is The Coronary Physiology Systems Market Growth Forecast?

The coronary physiology systems market size is expected to see strong growth in the next few years. It will grow to $2.12 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to growing adoption of integrated physiology and imaging platforms, increasing use of wireless and dual sensor guidewires, rising demand for non-invasive iFR and CFR measurements, expansion of ambulatory surgical centers offering cardiac diagnostics, adoption of AI-enabled data analysis for coronary physiology. Major trends in the forecast period include increasing adoption of wireless pressure guidewires, rising demand for integrated physiology and imaging systems, growing utilization of flow measurement systems for microvascular assessment, expansion of non-invasive coronary physiology modalities, rising focus on real-time data management and analysis software.

Global Coronary Physiology Systems Market Segmentation

1) By Product Type: Pressure Wire Systems, Flow Measurement Systems, Integrated Systems, Other Product Types 2) By Modality: Invasive, Non-Invasive 3) By Application: Fractional Flow Reserve (FFR), Instantaneous Wave-Free Ratio (iFR), Coronary Flow Reserve (CFR), Other Applications 4) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users Subsegments: 1) By Pressure Wire Systems: Wireless Pressure Guidewires, Wired Pressure Guidewires, Dual Sensor Pressure Guidewires, Temperature Sensor Enabled Pressure Guidewires 2) By Flow Measurement Systems: Coronary Flow Reserve Measurement Systems, Doppler Flow Velocity Systems, Thermodilution Based Flow Systems, Microvascular Resistance Measurement Systems 3) By Integrated Systems: Combined Physiology And Imaging Systems, Console Integrated Physiology Platforms, Co-Registration Systems, Multimodality Hemodynamic Monitoring Systems 4) By Other Product Types: Physiology Consoles, Data Management And Analysis Software, Accessories And Disposables, Calibration And Interface Modules

What Is The Driver Of The Coronary Physiology Systems Market?

The increasing prevalence of coronary artery disease is driving the growth of the coronary physiology systems market going forward. Coronary artery disease refers to a condition in which the coronary arteries become narrowed or blocked due to plaque buildup, reducing blood flow and oxygen supply to the heart muscle. The increasing prevalence of coronary artery disease is driven by sedentary lifestyles, as reduced physical activity contributes to obesity, high blood pressure, and poor cardiovascular health, increasing the risk of plaque buildup in the coronary arteries. Coronary physiology systems help diagnose coronary artery disease by providing precise measurements of blood flow and pressure within the coronary arteries, enabling clinicians to accurately assess the severity of arterial blockages and make informed decisions for targeted treatment. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2023, cardiovascular disease caused 919,032 deaths, representing roughly one-third of all deaths. Coronary heart disease continued to be the most common type, with approximately one in six cardiovascular deaths occurring in adults under the age of 65. Therefore, the increasing prevalence of coronary artery disease is driving the growth of the coronary physiology systems industry.

Key Players In The Global Coronary Physiology Systems Market

Major companies operating in the coronary physiology systems market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, Terumo Corporation, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, HeartFlow Inc., ACIST Medical Systems Inc., Pie Medical Imaging B.V., CathWorks Ltd., Insight Lifetech Co. Ltd., Keya Medical Co. Ltd., Opsens Inc., RADI Medical Systems AB, Medis Medical Imaging Systems B.V., Remedial Life Sciences Pvt. Ltd., Kamal Medtech Pvt. Ltd.

Global Coronary Physiology Systems Market Trends and Insights

Major companies operating in the coronary physiology systems market are focusing on developing advanced image-based functional assessment solutions to improve procedural efficiency, reduce reliance on invasive pressure wires, and enhance clinical decision-making during coronary interventions. Image-based functional assessment solutions are advanced diagnostic systems that interpret medical imaging data to determine the physiological significance of a condition, allowing functional evaluation without the use of invasive instruments. For instance, in April 2025, Medis Medical Imaging Systems, a Netherlands-based medical imaging software company, launched Medis QFR 3.0 in the United States. The latest image-based functional assessment version enhances workflow automation, delivers improved image processing capabilities, and provides faster, more accurate functional assessment of coronary lesions, supporting interventional cardiologists in optimizing treatment strategies for patients with coronary artery disease.

What Are Latest Mergers And Acquisitions In The Coronary Physiology Systems Market?

In December 2024, Terumo Health Outcomes, a US-based healthcare data analytics company, entered into a strategic partnership with Medis Medical Imaging to advance precision-driven cardiovascular care through integrated imaging analytics and clinical insights. The collaboration aims to enhance coronary physiology assessment and interventional decision-making by combining advanced quantitative imaging software with real-world clinical data and outcome analytics, ultimately improving patient outcomes in cardiovascular care. Medis Medical Imaging is a Netherlands-based company specializing in cardiovascular imaging software solutions, including quantitative coronary analysis and physiological assessment technologies used in catheterization laboratories.

Regional Insights

North America was the largest region in the coronary physiology systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Coronary Physiology Systems Market?

The coronary physiology systems market consists of sales of interface modules, hemodynamic recording systems, sensor-tipped guidewires, and calibration devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Coronary Physiology Systems Market Report 2026?

The coronary physiology systems market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the coronary physiology systems industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.